Items where authors include "Porter-Brown, B."

Article

Weidinger, S., Bieber, T., Cork, M.J. orcid.org/0000-0003-4428-2428 et al. (8 more authors) (2023) Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial. British Journal of Dermatology, 189 (5). pp. 531-539. ISSN 0007-0963